yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q26824762-0B637887-F9FE-4850-A1BE-620CB8EB959C
Q26824762-0B637887-F9FE-4850-A1BE-620CB8EB959C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26824762-0B637887-F9FE-4850-A1BE-620CB8EB959C
Denosumab, a RANK ligand inhibitor, for the management of bone loss in cancer patients
P2860
Q26824762-0B637887-F9FE-4850-A1BE-620CB8EB959C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26824762-0B637887-F9FE-4850-A1BE-620CB8EB959C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
413fc3935518d4dae418bf9979ae5a5d72108f29
P2860
Gonadotropin-releasing hormone agonists and fracture risk: a claims-based cohort study of men with nonmetastatic prostate cancer.